Organization
Shanghai Medinno Pharmaceutical Technology
1 clinical trial
Clinical trial
A Phase 1, First-in-Human, Single-center, Randomized, Double-masked, Placebo-controlled Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of MDI-1228_mesylate Ophthalmic Solution by Local Instillation in Adult Healthy VolunteersStatus: Recruiting, Estimated PCD: 2024-07-01